Brown Brothers Harriman & Co’s Pediatrix Medical MD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.42K	Hold	372	–	–	﹤0.01%	1440
2026 Q1	$7.96K	Hold	372	–	–	﹤0.01%	1398
2025 Q4	$7.96K	Buy	+372	New	+$7.62K	﹤0.01%	1393
2022 Q4	–	Sell	-311	Closed	-$5K	–	1402
2022 Q3	$5K	Buy	311 +12	+4%	+$242	﹤0.01%	1295
2022 Q2	$6K	Buy	+299	New	+$6.1K	﹤0.01%	1118
2018 Q2	–	Sell	-220	Closed	-$12K	–	850
2018 Q1	$12K	Hold	220	–	–	﹤0.01%	648
2017 Q4	$12K	Buy	+220	New	+$10.4K	﹤0.01%	728
2017 Q3	–	Sell	-80	Closed	-$5K	–	761
2017 Q2	$5K	Hold	80	–	–	﹤0.01%	701
2017 Q1	$6K	Hold	80	–	–	﹤0.01%	709
2016 Q4	$5K	Hold	80	–	–	﹤0.01%	763
2016 Q3	$5K	Hold	80	–	–	﹤0.01%	684
2016 Q2	$6K	Buy	+80	New	+$5.5K	﹤0.01%	697

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Brown Brothers Harriman & Co's MD Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its Pediatrix Medical (MD) position steady in Q2 2026 at 372 shares worth $9.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1440.

Brown Brothers Harriman & Co first reported a position in MD in Q2 2016 and has held it in 12 quarters since. The position peaked at $12K in Q1 2018. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Brown Brothers Harriman & Co held 372 shares of Pediatrix Medical worth $9.42K as of Q2 2026.
Brown Brothers Harriman & Co left its Pediatrix Medical share count unchanged in Q2 2026.
Pediatrix Medical made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1440 holding.
Brown Brothers Harriman & Co first reported a position in Pediatrix Medical in Q2 2016 and has held it in 12 quarters since.
Brown Brothers Harriman & Co's Pediatrix Medical position peaked at $12K in Q1 2018.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.